Product
Topical Corticosteroid
3 clinical trials
6 indications
Indication
Atopic DermatitisIndication
EczemaIndication
DermatitisIndication
AtopicIndication
Skin DiseasesIndication
GeneticClinical trial
A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase 3 Trial to Investigate the Efficacy and Safety of Lebrikizumab When Used With/Without Topical Corticosteroid Treatment in Participants With Moderate-To-Severe Atopic DermatitisStatus: Not yet recruiting, Estimated PCD: 2025-12-17
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Lebrikizumab Compared to Placebo in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-07-15
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab When Used in Combination With Topical Corticosteroid Treatment in Japanese Patients With Moderate-to-Severe Atopic DermatitisStatus: Completed, Estimated PCD: 2022-07-31